Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

Kowdley, KV; Bowlus, CL; Levy, C; Akarca, US; Alvares-da-Silva, MR; Andreone, P; Arrese, M; Corpechot, C; Francque, SM; Heneghan, MA; Invernizzi, P; Jones, D; Kruger, FC; Lawitz, E; Mayo, MJ; Shiffman, ML; Swain, MG; Valera, JM; Vargas, V; Vierling, JM; Villamil, A; Addy, C; Dietrich, J; Germain, JM; Mazain, S; Rafailovic, D; Tadde, B; Miller, B; Shu, JF; Zein, CO; Schattenberg, JM

Kowdley, KV (通讯作者),Liver Inst Northwest, 3216 NE 45th Pl,Ste 212, Seattle, WA 98105 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2023; ():

Abstract

Background Primary biliary cholangitis is a rare, chronic cholestatic liver disease characterized by the destruction of interlobular bile ducts, leadi......

Full Text Link